CARLA GARCIA: Open Payments
NPI 1487357331 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,255 in 95 payments from 14 companies in 2025. Trend: 2023 $51 · 2024 $825 · 2025 $2,255
Food & beverage: $2,255
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 27 | $658 |
| Vanda Pharmaceuticals Inc. | 12 | $340 |
| ABBVIE INC. | 15 | $307 |
| Otsuka America Pharmaceutical, Inc. | 10 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $126 |
| Alkermes, Inc. | 6 | $124 |
| Janssen Pharmaceuticals, Inc | 4 | $111 |
| Axsome Therapeutics, Inc. | 3 | $87 |
| Collegium Pharmaceutical, Inc. | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
Products named: Azstarys, VRAYLAR, REXULTI, FANAPT, HETLIOZ, CAPLYTA, ARISTADA, SPRAVATO.
Industry payments across FL — which companies pay providers there.
